CMR Surgical unveils portable surgical robotic system
The company’s team in Cambridge, UK, created and built the Versius surgical robotic system to meet the complex needs of laparoscopic surgery. The Versius system can be moved
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe company’s team in Cambridge, UK, created and built the Versius surgical robotic system to meet the complex needs of laparoscopic surgery. The Versius system can be moved
The Zika Virus assay is also approved for testing plasma or serum specimens to screen other living (heart-beating) or cadaveric (non-heart beating) organ donors and Human Cells, Tissues,
Profusa intends to use the proceeds to commercialize its first product, Profusa Lumee Oxygen Platform, which is used for continuous, real-time monitoring of tissue oxygen, and to develop its
The new ANGIOPULSE IABP incorporates a new system for IABP management based on pressure regulation. Extremely sophisticated, ANGIOPULSE builds on the Italian experience of Angiodroid Srl, a company
The hospital’s Epic EHR and varying brands as well as types of patient care devices such as physiologic monitors, ventilators, incubators, CRRT systems, and perfusion equipment are now
ViewRay’s MRIdian Linac has been selected to install at Centre Georges-François Leclerc (CGFL) in Dijon, France as part of a tender award contract with UNICANCER, a hospital network of
HJB partners with innovative technology developers that can aid in their like-minded goal of developing meaningful therapeutics at lower cost to dramatically expand global access to vital medicines
AFib, an abnormal heart rhythm characterized by rapid and irregular beating of the atria, is claimed to increase the risk of stroke fivefold. The study found that by
The BreathID 13C-MBT will be used to evaluate patient response to therapy. The studies are designed to evaluate the safety and efficacy of its investigational therapy BMS-986036 (PEG-FGF21)
The agreement includes the XL2 test, Indi’s lead oncology product, which offers a noninvasive means of ruling out cancer for patients with suspicious lung nodules. Financial terms of